DE LAURENTIIS, MICHELINO
DE LAURENTIIS, MICHELINO
DIPARTIMENTO DI MEDICINA CLINICA E CHIRURGIA
Targeted Therapy of Breast Cancer
2009 DE LAURENTIIS, Michelino; Zielinski, C.
Is there a standard chemotherapeutic regimen for hormone-refractory prostate cancer? Present and future approaches in the management of the disease.
2003 DI LORENZO, Giuseppe; Autorino, Riccardo; DE LAURENTIIS, Michelino; Bianco, Roberto; Lauria, Rossella; Giordano, A; De Sio, M; D'Armiento, Massimino; Bianco, Ar; DE PLACIDO, Sabino
Targeting HER2 as a therapeutic strategy for breast cancer: a paradigmatic shift of drug development in oncology.
2005 DE LAURENTIIS, Michelino; Cancello, G; Zinno, L; Montagna, E; Malorni, L; Esposito, A; Pennacchio, R; Silvestro, L; Giuliano, Mario; Giordano, A; Caputo, F; Accurso, A; DE PLACIDO, Sabino
Lapatinib in breast cancer: clinical experiences and future perspectives.
2010 Giampaglia, M; Chiuri, Ve; Tinelli, A; DE LAURENTIIS, Michelino; Silvestris, N; Lorusso, V.
Endocrine factors in the outcome of systemic adjuvant therapy of early breast cancer.
1993 A. R., Bianco; DE PLACIDO, Sabino; F., Perrone; Carlomagno, Chiara; DE LAURENTIIS, Michelino; L., Del Mastro; R., Lauria; Marinelli, Alfredo; C., Gallo
Effect of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
2005 Abe, O; Abe, R; Carlomagno, Chiara; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino
Cardiovascular complications of conventional and targeted adjuvant breast cancer therapy.
2011 Harbeck, N; Ewer, Ms; DE LAURENTIIS, Michelino; Suter, Tm; Ewer, Sm
Manuale di Oncologia Clinica
1996 Bianco, ANGELO RAFFAELE; E., Biondi; Carlomagno, Chiara; Ciardiello, Fortunato; Contegiacomo, Alma; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Lauria, Rossella; Marinelli, Alfredo; Matano, Elide; A., Morabito; Palmieri, Giovannella; Pepe, Stefano; F., Perrone; P., Tagliaferri; Tortora, Giampaolo
A meta-analysis on the interaction between HER-2 expression and response to endocrine treatment in advanced breast cancer.
2005 DE LAURENTIIS, Michelino; Arpino, Grazia; Massarelli, E; Ruggiero, A; Carlomagno, C; Ciardiello, F; Tortora, Giampaolo; D'Agostino, D; Caputo, F; Cancello, G; Montagna, E; Malorni, L; Zinno, L; Lauria, Rossella; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino
Twenty-year results of the Naples GUN randomized trial: predictive factors of adjuvant tamoxifen efficacy in early breast cancer.
2003 DE PLACIDO, Sabino; DE LAURENTIIS, Michelino; Carlomagno, Chiara; C., Gallo; F., Perrone; Pepe, Stefano; A., Ruggiero; Marinelli, Alfredo; Pagliarulo, Clorindo; Pettinato, Guido; G., Petrella; Bianco, ANGELO RAFFAELE
Prognostic significance of multifocality in primary breast cancer.
1994 Morabito, A.; Perrone, F.; Lauria, R.; Carlomagno, Chiara; Marinelli, Alfredo; DE LAURENTIIS, Michelino; Martignetti, A.; Pettinato, Guido; Panico, L.; Petrella, G.; Gallo, C.; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino
Taxane-Based Combinations As Adjuvant Chemotherapy of Early Breast Cancer: A Meta-Analysis of Randomized Trials
2008 DE LAURENTIIS, Michelino; Cancello, G.; D'Agostino, D.; Giuliano, Mario; Giordano, A.; Montagna, E.; Lauria, Rossella; Forestieri, Valeria; Esposito, A.; Silvestro, L.; Pennacchio, R.; Criscitiello, C.; Montanino, A.; Limite, Gennaro; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino
HER-2/neu receptor in prostate cancer development and progression to androgen independence.
2004 Giuseppe Di, Lorenzo; Riccardo, Autorino; DE LAURENTIIS, Michelino; Luca, Cindolo; Massimo, D'Armiento; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino
Second-line chemotherapy with a hybrid-alternating regimen of bolus 5FU modulated by methotrexate and infusional 5FU modulated by folinic acid in patients with metastatic colorectal cancer pretreated with 5FU. A phase 2 study.
2002 Carlomagno, Chiara; Lauria, Rossella; DE LAURENTIIS, Michelino; Arpino, Grazia; Massarelli, Erminia; Ferrara, Claudia; Milano, Andrea; Vernaglia, LOMBARDI ALESSANDRA; Costanzo, Raffaele; G., Catalano; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino
Mitomycin C and mitoxantrone in anthracycline-pretreated advanced breast cancer patients. A phase II study.
1994 F., Perrone; DE PLACIDO, Sabino; Carlomagno, Chiara; A., Gravina; DE LAURENTIIS, Michelino; L., Del Mastro; C., Gridelli; Pagliarulo, Clorindo; Bianco, ANGELO RAFFAELE
Antitumor activity of combined blockade of epidermal growth factor receptor and protein kinase A.
1996 Ciardiello, Fortunato; Damiano, Vincenzo; Bianco, Roberto; C., Bianco; G., Fontanini; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; J., Mendelsohn; Bianco, ANGELO RAFFAELE; Tortora, Giampaolo
Selecting high-risk early breast cancer patients: what to add to the number of metastatic nodes?
1996 F., Perrone; Carlomagno, Chiara; R., Lauria; DE LAURENTIIS, Michelino; A., Morabito; L., Panico; Pettinato, Guido; G., Petrella; C., Gallo; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino
A predictive index of axillary nodal involvement in operable breast cancer.
1996 DE LAURENTIIS, Michelino; C., Gallo; DE PLACIDO, Sabino; F., Perrone; Pettinato, Guido; G., Petrella; Carlomagno, Chiara; L., Panico; P., Delrio; Bianco, ANGELO RAFFAELE
Vinorelbine + mitomycin C as second-line treatment of metastatic breast cancer: a two-stage phase 2 study.
2000 DE PLACIDO, Sabino; Lauria, Rossella; F., Perrone; Vernaglia, LOMBARDI ALESSANDRA; Carlomagno, Chiara; E., Varriale; Costanzo, Raffaele; L., Leo; DE LAURENTIIS, Michelino; Bianco, ANGELO RAFFAELE
Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival.
1998 G., Fontanini; DE LAURENTIIS, Michelino; S., Vignati; S., Chinè; M., Lucchi; V., Silvestri; A., Mussi; DE PLACIDO, Sabino; Tortora, Giampaolo; Bianco, ANGELO RAFFAELE; W., Gullick; C. A., Angeletti; G., Bevilacqua; Ciardiello, Fortunato
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| Targeted Therapy of Breast Cancer | 8.01 Chairman di Sessioni di Convegni Internazionali | 2009 | DE LAURENTIIS, Michelino; Zielinski, C. | |
| Is there a standard chemotherapeutic regimen for hormone-refractory prostate cancer? Present and future approaches in the management of the disease. | 1.1 Articolo in rivista | 2003 | DI LORENZO, Giuseppe; Autorino, Riccardo; DE LAURENTIIS, Michelino; Bianco, Roberto; Lauria, Rossella; Giordano, A; De Sio, M; D'Armiento, Massimino; Bianco, Ar; DE PLACIDO, Sabino | |
| Targeting HER2 as a therapeutic strategy for breast cancer: a paradigmatic shift of drug development in oncology. | 1.1 Articolo in rivista | 2005 | DE LAURENTIIS, Michelino; Cancello, G; Zinno, L; Montagna, E; Malorni, L; Esposito, A; Pennacchio, R; Silvestro, L; Giuliano, Mario; Giordano, A; Caputo, F; Accurso, A; DE PLACIDO, Sabino | |
| Lapatinib in breast cancer: clinical experiences and future perspectives. | 1.1 Articolo in rivista | 2010 | Giampaglia, M; Chiuri, Ve; Tinelli, A; DE LAURENTIIS, Michelino; Silvestris, N; Lorusso, V. | |
| Endocrine factors in the outcome of systemic adjuvant therapy of early breast cancer. | 1.1 Articolo in rivista | 1993 | A. R., Bianco; DE PLACIDO, Sabino; F., Perrone; Carlomagno, Chiara; DE LAURENTIIS, Michelino; L., Del Mastro; R., Lauria; Marinelli, Alfredo; C., Gallo | |
| Effect of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials | 1.1 Articolo in rivista | 2005 | Abe, O; Abe, R; Carlomagno, Chiara; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino | |
| Cardiovascular complications of conventional and targeted adjuvant breast cancer therapy. | 1.1 Articolo in rivista | 2011 | Harbeck, N; Ewer, Ms; DE LAURENTIIS, Michelino; Suter, Tm; Ewer, Sm | |
| Manuale di Oncologia Clinica | 2.1 Contributo in volume (Capitolo o Saggio) | 1996 | Bianco, ANGELO RAFFAELE; E., Biondi; Carlomagno, Chiara; Ciardiello, Fortunato; Contegiacomo, Alma; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Lauria, Rossella; Marinelli, Alfredo; Matano, Elide; A., Morabito; Palmieri, Giovannella; Pepe, Stefano; F., Perrone; P., Tagliaferri; Tortora, Giampaolo | |
| A meta-analysis on the interaction between HER-2 expression and response to endocrine treatment in advanced breast cancer. | 1.1 Articolo in rivista | 2005 | DE LAURENTIIS, Michelino; Arpino, Grazia; Massarelli, E; Ruggiero, A; Carlomagno, C; Ciardiello, F; Tortora, Giampaolo; D'Agostino, D; Caputo, F; Cancello, G; Montagna, E; Malorni, L; Zinno, L; Lauria, Rossella; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino | |
| Twenty-year results of the Naples GUN randomized trial: predictive factors of adjuvant tamoxifen efficacy in early breast cancer. | 1.1 Articolo in rivista | 2003 | DE PLACIDO, Sabino; DE LAURENTIIS, Michelino; Carlomagno, Chiara; C., Gallo; F., Perrone; Pepe, Stefano; A., Ruggiero; Marinelli, Alfredo; Pagliarulo, Clorindo; Pettinato, Guido; G., Petrella; Bianco, ANGELO RAFFAELE | |
| Prognostic significance of multifocality in primary breast cancer. | 1.1 Articolo in rivista | 1994 | Morabito, A.; Perrone, F.; Lauria, R.; Carlomagno, Chiara; Marinelli, Alfredo; DE LAURENTIIS, Michelino; Martignetti, A.; Pettinato, Guido; Panico, L.; Petrella, G.; Gallo, C.; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino | |
| Taxane-Based Combinations As Adjuvant Chemotherapy of Early Breast Cancer: A Meta-Analysis of Randomized Trials | 1.1 Articolo in rivista | 2008 | DE LAURENTIIS, Michelino; Cancello, G.; D'Agostino, D.; Giuliano, Mario; Giordano, A.; Montagna, E.; Lauria, Rossella; Forestieri, Valeria; Esposito, A.; Silvestro, L.; Pennacchio, R.; Criscitiello, C.; Montanino, A.; Limite, Gennaro; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino | |
| HER-2/neu receptor in prostate cancer development and progression to androgen independence. | 1.1 Articolo in rivista | 2004 | Giuseppe Di, Lorenzo; Riccardo, Autorino; DE LAURENTIIS, Michelino; Luca, Cindolo; Massimo, D'Armiento; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino | |
| Second-line chemotherapy with a hybrid-alternating regimen of bolus 5FU modulated by methotrexate and infusional 5FU modulated by folinic acid in patients with metastatic colorectal cancer pretreated with 5FU. A phase 2 study. | 1.1 Articolo in rivista | 2002 | Carlomagno, Chiara; Lauria, Rossella; DE LAURENTIIS, Michelino; Arpino, Grazia; Massarelli, Erminia; Ferrara, Claudia; Milano, Andrea; Vernaglia, LOMBARDI ALESSANDRA; Costanzo, Raffaele; G., Catalano; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino | |
| Mitomycin C and mitoxantrone in anthracycline-pretreated advanced breast cancer patients. A phase II study. | 1.1 Articolo in rivista | 1994 | F., Perrone; DE PLACIDO, Sabino; Carlomagno, Chiara; A., Gravina; DE LAURENTIIS, Michelino; L., Del Mastro; C., Gridelli; Pagliarulo, Clorindo; Bianco, ANGELO RAFFAELE | |
| Antitumor activity of combined blockade of epidermal growth factor receptor and protein kinase A. | 1.1 Articolo in rivista | 1996 | Ciardiello, Fortunato; Damiano, Vincenzo; Bianco, Roberto; C., Bianco; G., Fontanini; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; J., Mendelsohn; Bianco, ANGELO RAFFAELE; Tortora, Giampaolo | |
| Selecting high-risk early breast cancer patients: what to add to the number of metastatic nodes? | 1.1 Articolo in rivista | 1996 | F., Perrone; Carlomagno, Chiara; R., Lauria; DE LAURENTIIS, Michelino; A., Morabito; L., Panico; Pettinato, Guido; G., Petrella; C., Gallo; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino | |
| A predictive index of axillary nodal involvement in operable breast cancer. | 1.1 Articolo in rivista | 1996 | DE LAURENTIIS, Michelino; C., Gallo; DE PLACIDO, Sabino; F., Perrone; Pettinato, Guido; G., Petrella; Carlomagno, Chiara; L., Panico; P., Delrio; Bianco, ANGELO RAFFAELE | |
| Vinorelbine + mitomycin C as second-line treatment of metastatic breast cancer: a two-stage phase 2 study. | 1.1 Articolo in rivista | 2000 | DE PLACIDO, Sabino; Lauria, Rossella; F., Perrone; Vernaglia, LOMBARDI ALESSANDRA; Carlomagno, Chiara; E., Varriale; Costanzo, Raffaele; L., Leo; DE LAURENTIIS, Michelino; Bianco, ANGELO RAFFAELE | |
| Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival. | 1.1 Articolo in rivista | 1998 | G., Fontanini; DE LAURENTIIS, Michelino; S., Vignati; S., Chinè; M., Lucchi; V., Silvestri; A., Mussi; DE PLACIDO, Sabino; Tortora, Giampaolo; Bianco, ANGELO RAFFAELE; W., Gullick; C. A., Angeletti; G., Bevilacqua; Ciardiello, Fortunato |